IHH Healthcare Set for Sustained Growth, Backed by Expansion Plans -- Market Talk

Dow Jones

2025/05/30

0105 GMT - IHH Healthcare is poised for continued growth, supported by a planned 28% increase in hospital bed capacity by 2028, mainly in Malaysia and India, Hong Leong IB analyst Chee Kok Siang says in a note. In Singapore and Hong Kong, IHH plans to expand across the care continuum with a focus on ambulatory and primary care, while also aiming to turn around its China operations, he says. Ongoing refurbishments at Singapore's Mount Elizabeth Hospital at Orchard may pressure margins until 2Q, he adds. Management remains open to merger-and-acquisition opportunities, targeting value-accretive assets in Malaysia, India, Turkey, and Europe, he notes. Hong Leong raises IHH's target price to MYR9.06 from MYR9.03 while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR6.86.(yingxian.wong@wsj.com)

(END) Dow Jones Newswires

May 29, 2025 21:05 ET (01:05 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2539906002"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2539906002\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2539906002?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-30 09:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2539906002","market":"fut","top_or_hot":-1,"title":"IHH Healthcare Set for Sustained Growth, Backed by Expansion Plans -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0105 GMT - IHH Healthcare is poised for continued growth, supported by a planned 28% increase in hospital bed capacity by 2028, mainly in Malaysia and India, Hong Leong IB analyst Chee Kok Siang says in a note. In Singapore and Hong Kong, IHH plans to expand across the care continuum with a focus on ambulatory and primary care, while also aiming to turn around its China operations, he says. Ongoing refurbishments at Singapore's Mount Elizabeth Hospital at Orchard may pressure margins until 2Q, he adds. Management remains open to merger-and-acquisition opportunities, targeting value-accretive assets in Malaysia, India, Turkey, and Europe, he notes. Hong Leong raises IHH's target price to MYR9.06 from MYR9.03 while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR6.86.(yingxian.wong@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 29, 2025 21:05 ET (01:05 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IHH Healthcare Set for Sustained Growth, Backed by Expansion Plans -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIHH Healthcare Set for Sustained Growth, Backed by Expansion Plans -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-05-30 09:05</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0105 GMT - IHH Healthcare is poised for continued growth, supported by a planned 28% increase in hospital bed capacity by 2028, mainly in Malaysia and India, Hong Leong IB analyst Chee Kok Siang says in a note. In Singapore and Hong Kong, IHH plans to expand across the care continuum with a focus on ambulatory and primary care, while also aiming to turn around its China operations, he says. Ongoing refurbishments at Singapore's Mount Elizabeth Hospital at Orchard may pressure margins until 2Q, he adds. Management remains open to merger-and-acquisition opportunities, targeting value-accretive assets in Malaysia, India, Turkey, and Europe, he notes. Hong Leong raises IHH's target price to MYR9.06 from MYR9.03 while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR6.86.(yingxian.wong@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 29, 2025 21:05 ET (01:05 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HCSG","symbol_name":"Healthcare Svcs Group Inc","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2539906002","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2539906002","pubTimestamp":1748567100,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0105 GMT - IHH Healthcare is poised for continued growth, supported by a planned 28% increase in hospital bed capacity by 2028, mainly in Malaysia and India, Hong Leong IB analyst Chee Kok Siang says in a note. In Singapore and Hong Kong, IHH plans to expand across the care continuum with a focus on ambulatory and primary care, while also aiming to turn around its China operations, he says. Ongoing refurbishments at Singapore's Mount Elizabeth Hospital at Orchard may pressure margins until 2Q, he adds. Management remains open to merger-and-acquisition opportunities, targeting value-accretive assets in Malaysia, India, Turkey, and Europe, he notes. Hong Leong raises IHH's target price to MYR9.06 from MYR9.03 while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR6.86.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HCSG":"Healthcare Svcs Group Inc","BK4137":"综合支持服务","BK6511":"医疗保健服务概念","BK6092":"保健护理机构","Q0F.SI":"IHH医疗保健集团"},"translate_title":"IHH Healthcare在扩张计划的支持下将持续增长——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCSG":1,"Q0F.SI":0.9},"content_text":"0105 GMT - IHH Healthcare is poised for continued growth, supported by a planned 28% increase in hospital bed capacity by 2028, mainly in Malaysia and India, Hong Leong IB analyst Chee Kok Siang says in a note. In Singapore and Hong Kong, IHH plans to expand across the care continuum with a focus on ambulatory and primary care, while also aiming to turn around its China operations, he says. Ongoing refurbishments at Singapore's Mount Elizabeth Hospital at Orchard may pressure margins until 2Q, he adds. Management remains open to merger-and-acquisition opportunities, targeting value-accretive assets in Malaysia, India, Turkey, and Europe, he notes. Hong Leong raises IHH's target price to MYR9.06 from MYR9.03 while maintaining a buy rating on the stock. Shares are 0.7% lower at MYR6.86.(yingxian.wong@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 29, 2025 21:05 ET (01:05 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}